Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

FDA Clears AIRS Medical's SwiftSight Body Composition AI Tool

7 October 2026 · By · Wire by Fusion42

Published

7 October 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at appliedradiology.com →

◆ Verified

Fusion42 · 7 October 2026 · Fusion42 review

AIRS Medical received FDA 510(k) clearance for SwiftSight Body Composition, an AI-powered MRI tool that provides quantitative muscle and fat distribution analysis in under five minutes, with SimonMed Imaging as its first customer.

This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it between 6 Oct 2026 and 7 Oct 2026.

◆ ◆ The Wire takeaway

You can now offer rapid, standardised muscle and fat analysis via MRI without adding new scanners or workflow complexity, opening clinical doors beyond traditional metrics like BMI.

◆ Coverage

3 sources · first reported 6 Oct 2026 · latest 7 Oct 2026

◆ Related on Wire

◆ Topics

Medtechfda-clearanceai-mribody-compositionmedtechclinical-ai